SAMSUNG BIOLOGICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 790,000 KRW | +0.25% |
|
+1.15% | +3.95% |
| May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
| Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SAMSUNG BIOLOGICS CO.,LTD. | Biopharmaceuticals | +0.25% | +1.15% | +3.95% | +1.41% | +169.17% | 41.34B |  | |  |
- Stock Market
- Equities
- A207940 Stock
- Charts Samsung Biologics Co.,Ltd.
- Relative Strength Chart
